Limited Partnership Sanderling VI is 10% at Pacira Pharmaceuticals, Inc. (PCRX). They have made 1 open-market trade across 1 company since 2011, most recently 2013-04-16.
CIK 0001429282
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.6M since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | BUY | 2011-02-08 | 2011-02-10 | $7.00 | $1.6M | -18.1% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.